
Stroke trial presentations accepted for prestigious international conference
Argenica Therapeutics, the WA based biotechnology company developing novel therapeutics to reduce brain tissue death after stroke and other acute...
Continue reading
This website may not work correctly in Internet Explorer. We recommend switching to a more secure modern web browser such as Microsoft Edge which is already installed on your computer.
Dr Stanley is a Project Manager for the Genetic Pharmacology group led by Professors’ Anthony Akkari, Jennifer Rodger and Sean Hood at the Perron Institute/UWA. Her current areas of research interest are the genetic metabolism of mental health medications in youth, and the impact of Covid-19 on primary healthcare workers.
Keep informed with our latest updates.
Stay up to date with our latest news and announcements.